2 completed, 2 terminated. 3 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Porfiromycin: new trials by email Literature Review of Porfiromycin trials Research Report on Porfiromycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients Porfiromycin, Placebo, Radiotherapy - Head and Neck Neoplasms | Phase 3 | Terminated | Boehringer Ingelheim | 3 | 2000-05-01 | 2014-07-08 |
| Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors Porfiromycin - Head and Neck Neoplasms | Phase 1 | Terminated | Boehringer Ingelheim | 3 | 1999-12-01 | 2014-08-06 |
| Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer porfiromycin, radiation therapy - Head and Neck Cancer | Phase 3 | Completed | Boehringer Ingelheim | 600 | 1997-12-01 | 2010-05-21 |
| Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer mitomycin C, porfiromycin, brachytherapy - Carcinoma of Unknown Primary, Head and Neck Cancer | Phase 3 | Completed | Yale University | 1992-11-01 | 2013-07-25 |
Head and Neck Neoplasms (4) · Squamous Cell Carcinoma of Head and Neck (2) · Neoplasms, Unknown Primary (1)
Boehringer Ingelheim (3) · Yale University (1)
United States (2)
James J. Fischer, MD, PhD (1) · Peter M. Glassman, MD, PhD (1)